Day One Biopharmaceuticals (DAWN) Earnings Date, Estimates & Call Transcripts $13.31 -1.01 (-7.05%) (As of 04:30 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Day One Biopharmaceuticals Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 24EstimatedActual EPS (Oct. 30) $0.38 Beat By $0.58 Consensus EPS (Oct. 30) -$0.20 Day One Biopharmaceuticals issued Q3 2024 earnings on October 30, 2024, reporting an EPS of $0.38, which beat analysts' consensus estimates of -$0.20 by $0.58. Quarterly revenue was reported to be $93.76 million, above analyst estimates of $15.05 million. With a trailing EPS of -$1.03, Day One Biopharmaceuticals' earnings are expected to decrease next year, from ($0.88) to ($0.99) per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckDAWN Upcoming EarningsDay One Biopharmaceuticals' next earnings date is estimated for Monday, February 24, 2025, based off prior year's reporting schedules. Get Day One Biopharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Day One Biopharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDAWN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DAWN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad StocksToTradeMy Top Trump Rally StocksThis Catalyst Hits Once Every 4 Years.. Every four years, on the day of the election, a catalyst is triggered. Over the last 20 years, this catalyst has caused 1,500 stocks to rise an average of 3,700%... within 90 days. And now, Tim Bohen is blowing the whole story wide open on Wednesday, November 20th at 8PM.Click here for details on your FREE RSVP. Day One Biopharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$0.71-$0.66-$0.68Q2 20243-$0.77-$0.67-$0.73Q3 20243-$0.73$0.11-$0.44Q4 20243-$0.73-$0.35-$0.60FY 202412-$2.94-$1.57-$2.46Q1 20252-$0.34-$0.29-$0.32Q2 20252-$0.29-$0.21-$0.25Q3 20252-$0.23-$0.18-$0.21Q4 20252-$0.20-$0.10-$0.15FY 20258($1.06)($0.78)($0.92) Day One Biopharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/24/2025(Estimated)------- 10/30/2024Q3 2024-$0.20$0.38+$0.58$0.38$15.05M$93.76M 7/30/2024Q2 2024-$0.75-$0.05+$0.70-$0.05$0.90M$8.19M 5/6/2024Q1 2024-$0.67-$0.72 -$0.05-$0.72-- 2/26/2024Q4 2023-$0.57-$0.64 -$0.07-$0.64-- 11/6/2023Q3 2023-$0.60-$0.54+$0.06-$0.54-- 8/7/2023Q2 2023-$0.60-$0.61 -$0.01-$0.61-- My Top Trump Rally Stocks (Ad)This Catalyst Hits Once Every 4 Years.. Every four years, on the day of the election, a catalyst is triggered. Over the last 20 years, this catalyst has caused 1,500 stocks to rise an average of 3,700%... within 90 days. And now, Tim Bohen is blowing the whole story wide open on Wednesday, November 20th at 8PM.Click here for details on your FREE RSVP.5/1/2023Q1 2023-$0.59-$0.59--$0.59-- 3/6/2023Q4 2022-$0.57-$0.56+$0.01-$0.56-- Day One Biopharmaceuticals Earnings - Frequently Asked Questions When is Day One Biopharmaceuticals's earnings date? Day One Biopharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates. Learn more on DAWN's earnings history. Did Day One Biopharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Day One Biopharmaceuticals (NASDAQ:DAWN) reported $0.38 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.20) by $0.58. Learn more on analysts' earnings estimate vs. DAWN's actual earnings. How can I listen to Day One Biopharmaceuticals's earnings conference call? The conference call for Day One Biopharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Day One Biopharmaceuticals's conference call transcript? The conference call transcript for Day One Biopharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Day One Biopharmaceuticals generate each year? Day One Biopharmaceuticals (NASDAQ:DAWN) has a recorded annual revenue of $101.95 million. How much profit does Day One Biopharmaceuticals generate each year? Day One Biopharmaceuticals (NASDAQ:DAWN) has a recorded net income of -$188.92 million. DAWN has generated -$1.03 earnings per share over the last four quarters. What is Day One Biopharmaceuticals's EPS forecast for next year? Day One Biopharmaceuticals's earnings are expected to decrease from ($0.88) per share to ($0.99) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies ARQT Earnings Date MNKD Earnings Date CSTL Earnings Date LMAT Earnings Date SGMO Earnings Date BDTX Earnings Date ATAI Earnings Date BNR Earnings Date NUVL Earnings Date KRYS Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run My Top Trump Rally Stocks (Ad)This Catalyst Hits Once Every 4 Years.. Every four years, on the day of the election, a catalyst is triggered. Over the last 20 years, this catalyst has caused 1,500 stocks to rise an average of 3,700%... within 90 days. And now, Tim Bohen is blowing the whole story wide open on Wednesday, November 20th at 8PM.Click here for details on your FREE RSVP. This page (NASDAQ:DAWN) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Day One Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
